共 467 条
[1]
Ferlay J(2015)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 E359-E386
[2]
Soerjomataram I(2016)ALK inhibitors in non-small cell lung cancer: the latest evidence and developments Ther Adv Med Oncol 8 32-47
[3]
Dikshit R(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249
[4]
Eser S(2021)Cancer statistics, 2021 CA Cancer J Clin 71 7-33
[5]
Mathers C(2008)Lung cancer N Engl J Med 359 1367-1380
[6]
Rebelo M(2002)Pathology of lung cancer Clin Chest Med 23 65-81
[7]
Parkin DM(2018)Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors Drug Discov Today 23 745-753
[8]
Forman D(2022)Long non-coding MELTF Antisense RNA 1 promotes and prognosis the progression of non-small cell lung cancer by targeting miR-1299 Bioengineered 13 10594-10604
[9]
Bray F(2022)Poor prognosis of intra-tumoural TRBV6-6 variants in EGFR-mutant NSCLC: results from the ADJUVANT-CTONG1104 trial Clin Transl Med 12 237-108
[10]
Sullivan I(2016)Implications of microRNAs in the treatment of gefitinib-resistant non-small cell lung cancer Int J Mol Sci 17 101-46